• Researching inorganic particulates as carriers for vaccine antigens, focusing on redispersion for clinical administration.• Conducting in-depth characterization to address gaps in fundamental properties driving particle agglomeration and redispersion in vaccine formulations.• Advancing material characterization for adjuvanted vaccine systems using rheological and optical techniques. I am developing a process to prevent this from happening commercially.

• Analyzed cellular response of cardiac cell lines to loaded particles on viscoelastic substrates, which better mimics tissueproperties in-vitro compared to linear elastic materials.• Tested Y-27632 and tPA-loaded nanogels on heart tissue models using PA gels and microgel films of varying viscosities.• Analyzed over 200 samples with immunofluorescence staining.

Managed budgeting, record-keeping, financial reporting, and resource allocation; collaborated on fundraising, financialplanning, and company relations.

• Developed a formula for automating Total Organic Carbon (TOC) input adjustment based on real-time data, improving pump speed accuracy and enhancing process control which projected a reduction in chemical usage by 26%.• Mapped out and analyzed friction loss in a 1.5-mile-long pipeline, recommending the replacement with a more efficient, unused pipe, which increased flow capacity by 32%.• Facilitated the replacement of pilot plant filters, addressing reoccurring organic content issues by diagnosing the inefficiency of nano-filters, leading to a 53% improvement in filter efficiency.• Identified, documented, and submitted work orders for over 50 air leaks throughout the facility.

• Actively contributed to the management of the wastewater treatment facility, consistently striving to improve its efficiency.• Identified areas within the plant for energy conservation, demonstrating a strong commitment to sustainable practices.• Conducted routine inspections, identifying and addressing potential health and safety hazards.